-
Mashup Score: 21
The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.
Source: Nature Reviews NeurologyCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2Genetic generalized epilepsies in adults — challenging assumptions and dogmas - Nature Reviews Neurology - 2 year(s) ago
In this Review, the authors consider how current understanding of four genetic generalized epilepsy syndromes that commonly occur in adults challenges traditional concepts about these conditions and suggests that they are not distinct but sit on a neurobiological continuum.
Source: Nature Reviews NeurologyCategories: Latest Headlines, NeurologyTweet-
New Review online now! Martin Holtkamp and colleagues consider how our understanding of genetic generalized epilepsy syndromes in adults challenges traditional concepts about these conditions & suggests they sit on a continuum https://t.co/aAGEMnLK1L #NewfromNRNeurology
-
-
Mashup Score: 1Disease modification is not all — we need symptomatic therapies for Alzheimer disease - Nature Reviews Neurology - 2 year(s) ago
A new study found methylphenidate to be effective in treating apathy in individuals with Alzheimer disease. At a time when the recent aducanumab approval is focusing attention on the promise of disease-modifying therapies, the new findings highlight the importance of developing better symptomatic treatment options for individuals with psychiatric disorders of Alzheimer disease.
Source: Nature Reviews NeurologyCategories: Latest Headlines, NeurologyTweet-
Latest News & Views: Jeffrey Cummings (@UNLV_SIHS @UNLVBrainHealth) discusses how positive results with methylphenidate for apathy in Alzheimer disease highlight the importance of continuing to develop symptomatic treatments https://t.co/YjdxgyqQU8 #NewfromNRNeurology
-
-
Mashup Score: 49
The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.
Source: Nature Reviews NeurologyCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
.@NatRevNeurol News & Views: Despite reports of neurological deficits in patients with COVID-19, the precise incidence of these manifestations has remained unknown. Two new studies have attempted to address this issue. https://t.co/9d1vnUL2n9 https://t.co/XYJzqIDpFM
-
-
Mashup Score: 310
The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.
Source: Nature Reviews NeurologyCategories: Latest Headlines, NeurologyTweet-
RT @EricTopol: Undercounting the neurologic cost of Covid https://t.co/r2OUBHpK2k by @AMannanBaig https://t.co/SHIbh65d2z
-
-
Mashup Score: 68
The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.
Source: Nature Reviews NeurologyCategories: Future of Medicine, Latest HeadlinesTweet-
RT @LEAD_Coalition: Counting neurological cost of #COVID19 https://t.co/7fsPD5JcR4 #coronavirus #Alzheimers #dementia @VirusesImmunity @a…
-
-
Mashup Score: 1T cells step up after SARS-CoV-2 vaccination with B cell depletion - Nature Reviews Neurology - 2 year(s) ago
Detailed immunological analysis in a new study provides insight into the mechanisms of immune responses after SARS-CoV-2 vaccination in people who are receiving B cell-depleting therapy for multiple sclerosis. The findings have implications for clinical practice, but more questions about SARS-CoV-2 vaccination and immunosuppression remain.
Source: Nature Reviews NeurologyCategories: Latest HeadlinesTweet-
Interesting paper that adds to our understanding of the vaccine response even in patients on B cell depleting therapy - with a REDUNDANT and complex immune system, T cells are still there to protect https://t.co/2f4tHNlHiu
-
-
Mashup Score: 12
The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.
Source: Nature Reviews NeurologyCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @LEAD_Coalition: Counting neurological cost of #COVID19 https://t.co/7fsPD5JcR4 #coronavirus #Alzheimers #dementia @VirusesImmunity @a…
-
-
Mashup Score: 227
The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.
Source: Nature Reviews NeurologyCategories: Latest Headlines, Oncologists2Tweet-
RT @Dr2NisreenAlwan: This is the virus that is spreading uncontrollably among children. https://t.co/DPhwJ1WxBp
-
-
Mashup Score: 227
The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.
Source: Nature Reviews NeurologyCategories: Latest Headlines, PediatricsTweet-
RT @Dr2NisreenAlwan: This is the virus that is spreading uncontrollably among children. https://t.co/DPhwJ1WxBp
-
.@NatRevNeurol News & Views: Despite reports of neurological deficits in patients with COVID-19, the precise incidence of these manifestations has remained unknown. Two new studies have attempted to address this issue. https://t.co/4cYiFw1B9o https://t.co/BHmhJpgvCJ